Stockreport

Precipio Pathology Sales Performance Metrics Demonstrate Substantial Improvement in Q1-2019

Precipio, Inc.  (PRPO) 
US:NASDAQ Investor Relations: precipiodx.com/investors.html
PDF NEW HAVEN, Conn., May 30, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today provides shareholders with three of the ke [Read more]